Letter to the Editor

Bone Marrow Transplantation (2007) 39, 809–810; doi:10.1038/sj.bmt.1705681; published online 23 April 2007

Graft-versus-tumour effect in refractory metastatic neuroblastoma

A Marabelle1,2,3, C Paillard1,3, A Tchirkov2,4, P Halle1,2,3, J Chassagne4, F Deméocq1,2,3 and J Kanold1,2,3

  1. 1Centre Hospitalier et Universitaire de Clermont-Ferrand, Service de Pédiatrie B et Unité Bioclinique de Thérapie Cellulaire, Clermont-Ferrand, France
  2. 2Faculté de Médecine, Université Clermont1, Clermont-Ferrand, France
  3. 3INSERM, CIC501, Clermont-Ferrand, France
  4. 4Laboratoire d'immunologie, Centre Jean Perrin, Clermont-Ferrand, France

Correspondence: A Marabelle, E-mail: amarabelle@chu-clermontferrand.fr

Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

RESEARCH

Graft-versus-tumour effect in refractory metastatic neuroblastoma

Bone Marrow Transplantation Letter

Ex vivo expansion of autologous PB CD34+ cells provides a purging effect in children with neuroblastoma

Bone Marrow Transplantation Original Article

28 years of high-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 procedures

Bone Marrow Transplantation Original Article

Extra navigation

.

naturejobs

More science jobs
Post a job for free
ADVERTISEMENT